Chiusura precedente | 5,26 |
Aperto | 5,27 |
Denaro | 5,30 x 600 |
Lettera | 5,33 x 600 |
Min-Max giorno | 5,26 - 5,36 |
Intervallo di 52 settimane | 4,38 - 8,45 |
Volume | |
Media Volume | 920.458 |
Capitalizzazione | 407,033M |
Beta (5 anni mensile) | 0,18 |
Rapporto PE (ttm) | 7,39 |
EPS (ttm) | 0,72 |
Prossima data utili | 08 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 7,69 |
InteliSwab® test revenue of $47.5 million in Q2 Q2 Core revenue of $37.9 million grew 4% sequentially and 3% year-over-year Q2 GAAP EPS of $(0.07); Q2 Non-GAAP EPS of $0.09 Grew cash balance to $185.9 million as of June 30, 2023 InteliSwab® orders are expected to generate at least $70 million of revenue in second half of 2023 On track to achieve operating cash flow breakeven on core business by end of 2024 BETHLEHEM, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR
BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 second quarter financial results and certain business developments for 5:00 pm ET on Thursday, August 3, 2023. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration
BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W. McMahon, CMA, MBA, to the Company’s Board of Directors, effective July 31, 2023. Including McMahon, the company’s Board of Directors has seven members. Mr. McMahon is Senior Vice President and Chief Financial Officer for Agilent Tec